Directorate change

AI SummaryClose X

SkinBioTherapeutics plc announced that its Chief Financial Officer, Emily Bertram, will depart on June 30, 2026, after making significant contributions to the company's financial stewardship and governance, including identifying issues related to the former CEO's conduct. The company has appointed an interim CFO with extensive experience as a Chartered Accountant and AIM-listed plc CFO to strengthen financial controls and reporting, while a search for a permanent CFO is underway.

Disclaimer*

UK 100

Latest directors dealings